What causes african sleeping sickness

Overview

African sleeping sickness, or human African trypanosomiasis (HAT), is a serious parasitic disease that affects hundreds of thousands of people, primarily in rural sub-Saharan Africa. It is caused by microscopic parasites called trypanosomes, which are transmitted to humans through the bite of infected tsetse flies. The disease is characterized by its progression through distinct stages, eventually affecting the central nervous system if left untreated, leading to severe neurological symptoms and often death.

What are Trypanosomes?

The causative agents of African sleeping sickness are single-celled protozoan parasites belonging to the genus *Trypanosoma*. Specifically, the species *Trypanosoma brucei* is responsible for the human disease. This species is further divided into two subspecies that cause the human illness: *Trypanosoma brucei gambiense* and *Trypanosoma brucei rhodesiense*. *T. b. gambiense* is responsible for the vast majority of cases (over 95%) and typically causes a chronic, slow-progressing form of the disease, while *T. b. rhodesiense* causes a more acute, rapidly progressing form and accounts for about 5% of cases. A third subspecies, *Trypanosoma brucei brucei*, infects animals but not humans.

The Role of the Tsetse Fly

The transmission of trypanosomes from animals or infected humans to healthy individuals is facilitated by the tsetse fly (genus *Glossina*). These biting flies are found in various habitats across sub-Saharan Africa. When a tsetse fly bites an infected host (human or animal) and ingests blood containing trypanosomes, the parasites undergo development within the fly. Later, when the infected tsetse fly bites another person, it injects the infective trypanosomes into the bloodstream, thus initiating the infection. The type of tsetse fly and its habitat can influence the predominant subspecies causing the disease in a particular region.

Transmission Cycle

The transmission cycle of African sleeping sickness is an enzootic-epizootic-epidemic cycle. The parasite circulates in wild animal populations (enzootic), which can spill over into domestic animals and humans (epizootic). In areas where *T. b. gambiense* is prevalent, humans are the main reservoir, and the disease can spread directly from person to person via tsetse fly bites (epidemic). The life cycle of the trypanosome involves both the mammalian host and the tsetse fly, with complex developmental stages occurring in each. The fly becomes infective after ingesting blood from an infected host and can transmit the parasite to a new host about 10-20 days later.

Symptoms and Disease Progression

African sleeping sickness typically progresses in two stages. The first stage, the hemolymphatic stage, begins after the tsetse fly bite. A characteristic lesion called a trypanosomal chancre may develop at the site of the bite, usually appearing a few days to a week after infection. This stage is characterized by symptoms such as fever, headaches, joint pain, itching, and swollen lymph nodes (particularly the posterior cervical lymph nodes, known as Winterbottom's sign in cases of *T. b. rhodesiense*). Parasites are present in the blood and lymph fluid during this stage.

The second stage, the neurological stage, occurs when the parasites cross the blood-brain barrier and invade the central nervous system. This stage is more serious and is marked by a range of neurological and psychiatric symptoms, including confusion, personality changes, sleep disturbances (hence the name 'sleeping sickness'), difficulty walking, seizures, and eventually coma. The progression to this stage is much faster with *T. b. rhodesiense* infection (weeks to months) compared to *T. b. gambiense* infection (months to years). Without timely and appropriate treatment, the neurological stage is almost invariably fatal.

Risk Factors and Geographic Distribution

The risk of contracting African sleeping sickness is highest for people living in or traveling to rural areas of sub-Saharan Africa where tsetse flies are present. The geographical distribution of the disease is closely tied to the distribution of the tsetse fly, which inhabits a wide belt across the continent, particularly in woodlands, savannas, and riverine vegetation.

Factors contributing to the persistence and spread of the disease include poverty, lack of access to healthcare, population movement, and the presence of animal reservoirs for the parasite. Control efforts often focus on vector control (reducing tsetse fly populations), early detection and treatment of infected individuals, and surveillance in at-risk communities.